98%
921
2 minutes
20
Background: Artificial intelligence (AI) tools for large vessel occlusion (LVO) detection are increasingly used in acute stroke triage to expedite diagnosis and intervention. However, variability in access and workflow integration limits their potential impact. This study assessed current usage patterns, access disparities, and integration levels across U.S. stroke programs.
Methods: Cross-sectional, web-based survey of 97 multidisciplinary stroke care providers from diverse institutions. Descriptive statistics summarized demographics, AI tool usage, access, and integration. Two-proportion Z-tests assessed differences across institutional types.
Results: Most respondents (97.9%) reported AI tool use, primarily Viz AI and Rapid AI, but only 62.1% consistently used them for triage prior to radiologist interpretation. Just 37.5% reported formal protocol integration, and 43.6% had designated personnel for AI alert response. Access varied significantly across departments, and in only 61.7% of programs did all relevant team members have access. Formal implementation of the AI detection tools did not differ based on the certification (z = -0.2; = 0.4) or whether the program was academic or community-based (z =-0.3; = 0.3).
Conclusions: AI-enabled LVO detection tools have the potential to improve stroke care and patient outcomes by expediting workflows and reducing treatment delays. This survey effectively evaluated current utilization of these tools and revealed widespread adoption alongside significant variability in access, integration, and workflow standardization. Larger, more diverse samples are needed to validate these findings across different hospital types, and further prospective research is essential to determine how formal integration of AI tools can enhance stroke care delivery, reduce disparities, and improve clinical outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/01616412.2025.2515194 | DOI Listing |
Front Neurol
August 2025
Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Introduction: Reperfusion failure (RF) describes a condition in which patients suffering a large vessel occlusion (LVO) stroke present insufficient tissue reperfusion and recovery despite optimal mechanical thrombectomy (MT) results. Approximately 50% of patients suffering from LVO are affected. Our current understanding of the underlying pathomechanisms is limited and mostly based on rodent models.
View Article and Find Full Text PDFFront Neurosci
August 2025
Department of Neurology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China.
Background: Acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) is a leading cause of disability and mortality worldwide. Although endovascular thrombectomy (EVT) has significantly improved outcomes, many patients do not achieve early neurological improvement (ENI) despite timely reperfusion. This study aims to investigate the peripheral blood mRNA molecular characteristics and underlying mechanisms associated with ENI after EVT in AIS-LVO patients, to inform individualized treatment and optimize prognosis.
View Article and Find Full Text PDFSci Rep
September 2025
Department of Neurology, Wuhan No. 1 Hospital, Wuhan, China.
Thrombus enhancement sign (TES) is a potential imaging biomarker for differentiating embolic large vessel occlusion (embo-LVO) from intracranial atherosclerosis-related LVO (ICAS-LVO) in basilar artery occlusion (BAO). This study evaluates the association between TES and BAO etiology and its predictive value in distinguishing embo-LVO from ICAS-LVO. We conducted a prospective, two-center cohort study of acute ischemic stroke (AIS) patients with BAO who underwent EVT between January 2020 and September 2024.
View Article and Find Full Text PDFJ Neurointerv Surg
August 2025
Stroke Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Background: Rapid identification of large vessel occlusion (LVO) in acute ischemic stroke (AIS) is essential for reperfusion therapy. Screening tools, including Artificial Intelligence (AI) based algorithms, have been developed to accelerate detection but rely heavily on pre-test LVO prevalence. This study aimed to review LVO prevalence across clinical contexts and analyze its impact on AI-algorithm performance.
View Article and Find Full Text PDFBrain Sci
July 2025
Institute of Neuroradiology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Objective: This study aimed to evaluate whether modifying the post-processing algorithm of Twin-Spiral Dual-Energy computed tomography (DECT) improves infarct detection compared to conventional Dual-Energy CT (DECT) and Single-Energy CT (SECT) following endovascular therapy (EVT) for large vessel occlusion (LVO).
Methods: We retrospectively analyzed 52 patients who underwent Twin-Spiral DECT after endovascular stroke therapy. Ten patients were used to generate a device-specific parameter ("y") using an AI-based neural network (SynthSR).